Colin Campbell
About Colin Campbell
Colin Campbell is the Director of CAR-T Manufacturing Operations at Bristol-Myers Squibb and Associate Director of Process Development at Elusys Therapeutics, Inc., with over 30 years of experience in the pharmaceutical and biotechnology industries.
Company
Colin Campbell is currently employed at Bristol-Myers Squibb and Elusys Therapeutics, Inc. At Bristol-Myers Squibb, he serves as the Director of CAR-T Manufacturing Operations. Elusys Therapeutics, Inc. employs him as the Associate Director of Process Development, based in Pine Brook, New Jersey, United States.
Title
Colin Campbell holds two significant roles in his professional career. He is the Director of CAR-T Manufacturing Operations at Bristol-Myers Squibb. Parallelly, he functions as the Associate Director of Process Development at Elusys Therapeutics, Inc.
Education and Expertise
Colin Campbell graduated from Rutgers University, Cook College, in 1991 with a Bachelor of Science degree. With over 30 years of experience in the pharmaceutical and biotechnology industries, he specializes in CAR-T cell therapy manufacturing operations. His expertise extends to process development and technical services.
Background
Colin Campbell's professional journey spans various roles in notable organizations. Starting as an Associate Scientist at American Health Foundation from 1990 to 1995, he then moved to ICN Pharmaceuticals Diagnostics Division as a Technical Services Chemist from 1995 to 1997. His tenure at Roche from 1997 to 2006 as a Group Leader provided him with substantial leadership experience. Since February 2020, he has been with Bristol-Myers Squibb, contributing to CAR-T manufacturing operations.